Debt to Equity Ratio (Annual)

Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity

ResMed Inc. (RMD) had Debt to Equity Ratio of 0.35 for the most recently reported fiscal year, ending 2023-06-30.

Quarterly Annual

Figures for fiscal year ending 2023-06-30

Income Statement Financials
Revenue	$4.22B
Net Income	$897.56M
Cost of Goods Sold	$1.87B
Gross Profit	$2.36B
Operating Expenses	$3.09B
Operating Income	$1.13B
Non-Operating Income/Expense	$-30.21M
Pre-Tax Income	$1.10B
Normalized Pre-Tax Income	$1.10B
Income after Taxes	$897.56M
Income from Continuous Operations	$897.56M
Consolidated Net Income/Loss	$897.56M
Normalized Income after Taxes	$897.56M
EBIT	$1.13B
EBITDA	$1.33B
Weighted-Average Shares Outstanding (Basic)	146.76M
Weighted-Average Shares Outstanding (Diluted)	147.46M
Earnings per Share (EPS) (Basic)	$6.12
Earnings per Share (EPS) (Diluted)	$6.09
Balance Sheet Financials
Current Assets	$2.37B
Property, Plant, and Equipment	$537.86M
Long-Term Assets	$4.38B
Total Assets	$6.75B
Current Liabilities	$758.53M
Long-Term Debt	$1.43B
Long-Term Liabilities	$1.86B
Total Liabilities	$2.62B
Common Equity	$4.13B
Tangible Shareholders Equity	$807.26M
Shareholders Equity	$4.13B
Common Shares Outstanding	147.06M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$693.30M
Cash Flow from Investing Activities	$-1.16B
Cash Flow from Financial Activities	$422.87M
Beginning Cash	$273.71M
End Cash	$227.89M
Increase/Decrease in Cash	$-45.82M
Stock-Based Compensation	$71.14M
Common Stock Dividends Paid	$-258.28M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.12
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.26
Debt to Equity Ratio	0.35
Gross Margin	55.78%
Operating Margin	26.80%
EBIT Margin	26.80%
EBITDA Margin	31.48%
Pre-Tax Profit Margin	26.09%
Profit Margin	21.25%
Free Cash Flow	$573.63M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.63
Inventory Turnover	1.87
Receiveable Turnover	5.99
Days Sales in Receivables	60.93
Return on Equity	21.73%
Return on Tangible Equity	111.19%
Return on Assets	13.29%
Return on Investments	16.14%
Book Value Per Share	$28.08
Free Cash Flow per Share	$3.89
Operating Cash Flow per Share	$4.70

Data from Zacks Investment Research, Inc.